UK MHRA approves AbbVie’s migraine prevention drug Aquipta
UK MHRA approves AbbVie’s migraine prevention drug Aquipta. [Quantung Pharma – Quantung.com]
UK MHRA approves AbbVie’s migraine prevention drug Aquipta
European PFAS ban would burden drug companies and packagers
Pharma industry: Proposed ‘forever chemicals’ ban would stifle innovation, access to drugs
Avian influenza cases seen in mammals pose low risk for humans, health agencies say
EU chemical and pharmaceutical trade: robust growth
Importance of data analysis in healthcare
A Degree in Health Science Could Be Just What the Doctor Ordered